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SocietyIn this issue of Osteoarthritis and Cartilage, Dr Pritzker
and colleagues1, under the auspices of the Osteoarthritis
Research Society International (OARSI), present a recom-
mended methodology for grading and staging histopatho-
logic changes in osteoarthritic cartilage. As the authors
note, the commonly used grading systems developed by
Collins et al.2,3 and Mankin et al.4, utilized by investigators
for decades, have been formally questioned as to reproduc-
ibility and validity5e7. A major deﬁciency of current scoring
systems relates to the difﬁculty in translating focal pathologic
changes into a score that encompasses the overall joint
pathologic response. For example, utilizing the Mankin His-
tological Histochemical Grading System (HHGS), a focal
area of cartilage may demonstrate a pathologic composite
characterized by cellular changes, loss of Safranin O matrix
staining, erosion, and tidemark vessel abnormalities yield-
ing a score of 14 points, the maximal score attainable. In
contrast, in another situation, pathologic changes observed
may be more superﬁcial, yielding a Mankin score of 5, but
with pathologic changes encompassing an extended topo-
graphic area; the difﬁculty equating the two scenarios is
readily apparent. Accordingly, the recommendation of the
authors that scoring should include both grade and stage
promises potential for developing a more accurate and valid
comparative scoring methodology.
A second deﬁcit in the current scoring systems is the ef-
ﬁcacy limitation related to utilizing these methodologic ap-
proaches in human studies wherein histopathologic
scoring must necessarily be based on small blocks of path-
ologic tissue available at biopsy. In this situation, scoring
using staging as well as grade is difﬁcult. In this scenario,
scoring taking into account stage and grade is possible if
gross and histologic ﬁndings closely correlate, so that histo-
pathologic grades can be validly inferred from gross patho-
logic ﬁndings.
An additional issue is the question as to whether histologic
progression of osteoarthritis (OA) is the same amongst
different animal models (e.g. trauma-induced partial-
meniscectomy models vs spontaneous mouse or guinea
pig models), and between animal models and humans.
The authors have done an admirable job of deﬁning the
caveats related to current grading systems, and the hurdles
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particular, as the authors note, standardization of deﬁnitions
of OA cartilage histopathology, exclusion criteria for other
forms of arthritis, differences between joints and each joint
compartment, and methodologies related to histopathologic
preparation and staining of standard sections all represent
areas which need to be addressed. Of particular import in
this regard is standardization of histologic block/section
preparation and methodologies for ﬁxation and staining of
cartilage.
The proposed methods for grading and staging are well
deﬁned and, if validated, would represent an advance in
histopathologic assessment. Given that staging requires as-
sessment of a whole joint or, at the least, one joint quadrant,
such validation will likely necessarily occur ﬁrst in studies of
animal models. Correlations of gross and histopathologic
changes are feasible in humans utilizing pathologic materi-
als from individuals undergoing joint replacement whereby
gross and histopathologic ﬁndings can be correlated. Unfor-
tunately, these studies would reﬂect late stage disease, not
providing information on earlier aspects of the disease
process.
Although this proposal provides a clearly written treatise
comprising background, caveats and recommendations,
some questions and comments might be in order. For
example, no mention is made of tidemark vascular
responses; do the authors believe that these are no longer
of import in deﬁning pathology? Table 2, is complex; it
might be helpful if the criteria could be separated into those
ﬁndings required for the grade, and those ﬁndings that may
be present in addition, described as optional (the authors
do provide a Gconnotation which might represent such
a distinction). Although there may be deﬁciencies in the
Mankin system, depending on whether studies were being
performed in animals or in humans, the Mankin system
has served us well for many years. Accordingly, the
statement that it is ‘‘not valid’’ seems to be a bit strong. In
Appendix 2, the glossary is of interest, but might be
abbreviated for practical use; in its present form it is
probably ‘‘more than one needs to know’’.
In summary, the proposed methodology for grading and
staging OA cartilage histopathology represents a signiﬁcant
step forward in addressing advances in an area of
methodologic need. The authors provide alternative
methods for scoring; it would have been helpful to have
presented an opinion as to what method of scoring they
would suggest that investigators use at the present time,
prior to validation. All investigators interested in studies of
OA pathophysiology will appreciate the effort which went
into these new recommendations. OARSI, in its leadership
2 Editorialrole in the ﬁeld of OA clinical and basic research, is to be
commended for its farsightedness in recognizing the need
for an advance in this ﬁeld, and for its sponsorship of the
approach. I anticipate that under OARSI guidance
validation studies will be expeditiously undertaken to
complete the process.
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